HK EGFP-Cap-D2 Cells
| Unit |
3 x 10^6 cells/ml |
|---|---|
| Cell Type |
Stable (KO/Expressing) Cells |
| Tissue Type |
Reporter-labeled cells |
| Organism |
Human |
| Donor History |
Carcinoma |
| Growth Properties |
Monolayer ,adherent |
| Growth Conditions |
Culture medium: DMEM ,w: 4.5 g/L Glucose ,w: 4 mM L-Glutamine ,w: 3.7 g/L NaHCO3 ,w: 1.0 mM Sodium pyruvate (Cytion article number 820300a). Supplements: Supplement the medium with 10% FBS. Dissociation reagent: Accutase. Seeding density: 1 x 10⁴ cells/cm². Freeze medium: As a cryopreservation medium ,we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability ,or CM-1 (Cytion catalog number 800100) ,which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. Incubation atmosphere: 37°C ,5% CO2 ,humidified atmosphere. |
| Immortalization Method | |
| Full Information |
The HK EGFP-Cap-D2 cell line is an engineered variant of Hela Kyoto cells, specifically designed for advanced research in cellular biology and genetic engineering. This cell line expresses enhanced green fluorescent protein (EGFP) fused to the C-terminus of the D2 dopamine receptor, enabling the visualization of receptor dynamics and distribution in real-time under fluorescence microscopy. This feature is particularly beneficial for studying receptor trafficking, signaling pathways, and the effects of pharmacological agents on D2 receptor behavior.
These cells are used extensively in neurological research to understand better the mechanisms underlying dopamine signaling, which is crucial in many neurological disorders such as Parkinson’s disease, schizophrenia, and depression. The fusion of EGFP to the D2 receptor does not affect the receptor’s normal function or its cellular localization, making HK EGFP-Cap-D2 a valuable tool for physiological and pathological studies. The stable expression of EGFP also allows for longitudinal studies in live cells, providing insights into the dynamic processes of receptor regulation and interaction with other cellular components.
Společnost Cytion vznikla v roce 2004 v německém Heidelbergu s jasným vědeckým posláním: dodávat ověřené lidské a zvířecí buněčné linie bez kontaminace, připravené za přísně kontrolovaných laboratorních podmínek.
Postupně se vypracovala ve spolehlivou buněčnou banku, která slouží akademickým laboratořím, biotechnologickým firmám i farmaceutickým výzkumným týmům po celém světě. Klade přitom důraz na reprodukovatelnost výsledků, přísnou kontrolu kvality a dlouhodobá partnerství.
Mikrobiologické aplikace
NGS
Rapid testy
PCR plasty
Třepačky
Suché lázně
Fluorometry
Buněčné kultury
PCR, qPCR, RT
Detekce Mycoplasmat
Reverzní transkripce
Alergie
Intolerance
Elisa
Imunologické analyzátory
Veterinární imunologie
Alergie u zvířat
Intolerance u zvířat
Čtečky identifikačních čipů
Termočipy
Biochemie
Imunoanalýza

